Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

Immunogenicity of intraperitoneal and intranasal liposome adjuvanted VLP vaccines against SARS-CoV-2 infection

Abstract Humans get SARS-CoV-2 infection mainly through inhalation; thus, vaccine that induces protective immunity at the virus entry site is important for early control of the infection. In this study, two anionic liposome (L)-adjuvanted VLP vaccines against SARS-CoV-2 were formulated. Baculovirus-...

Full description

Bibliographic Details
Main Authors: Monrat Chulanetra, Primana Punnakitikashem, Kodchakorn Mahasongkram, Wanpen Chaicumpa, Kantaphon Glab-ampai
Format: Article
Language:English
Published: Nature Portfolio 2024-11-01
Series:Scientific Reports
Subjects:
Baculovirus-insect cell system
COVID-19
Liposome
SARS-CoV-2
Virus-like particles
VLP vaccines
Online Access:https://doi.org/10.1038/s41598-024-79122-7

Internet

https://doi.org/10.1038/s41598-024-79122-7

Similar Items